LifeStance Health Group (LFST) vs. Its Peers Financial Survey

LifeStance Health Group (NASDAQ:LFST) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare LifeStance Health Group to similar businesses based on the strength of its profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings.

Institutional and Insider Ownership

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares LifeStance Health Group and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
LifeStance Health Group	$1.42 billion	$9.66 million	100.77
LifeStance Health Group Competitors	$21.30 billion	$288.48 million	7.08

LifeStance Health Group’s competitors have higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares LifeStance Health Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
LifeStance Health Group Competitors	-7.83%	-141.62%	-1.53%

Risk and Volatility

LifeStance Health Group has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, LifeStance Health Group’s competitors have a beta of 0.97, indicating that their average share price is 3% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for LifeStance Health Group and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0	4	6	1	2.73
LifeStance Health Group Competitors	1836	7670	13196	813	2.55

LifeStance Health Group presently has a consensus price target of $13.12, indicating a potential upside of 0.19%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.68%. Given LifeStance Health Group’s competitors higher possible upside, analysts plainly believe LifeStance Health Group has less favorable growth aspects than its competitors.

Summary

LifeStance Health Group beats its competitors on 8 of the 13 factors compared.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.